46 2. DETERMINATION OF THE IPI MEASURE › 2.3. Union interest › 2.3.1. Interest of Union economic operators, Regulation (EU) 2025/1197

In forcesince 19 Jun 2025

As referred to in recital 39, the Union has a significant trade surplus with the rest of the world in the medical devices sector, which demonstrates that the Union’s manufacturers hold a strong global competitive position in this sector and have a significant production base. The value of the PRC’s procurement market for medical devices can be estimated at approximately EUR 128 billion [For 2023, the total Chinese market for medical devices was estimated at EUR 160 billion. While there is no available data on the precise total value of the public procurement market, public hospitals accounted for 83,5 % of the total patient visits nationwide during the same year; this provides a strong indication that the share of the public procurement market in the value of the medical devices market may be estimated at around 80 %, i.e. EUR 128 billion.]. The removal of the discriminatory barriers in this market would offer considerable growth opportunities for Union economic operators. The adoption of the IPI measure would create leverage to convince the GOC to remove the discriminatory barriers, thereby establishing a more level playing field in a large international market that will be in the advantage of Union economic operators.